(Q30275579)

14 June 2017

title

The role of variants regulating metformin transport and action in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

14 June 2017

main subject

1 reference

1 reference

1 reference

Cindy T Pau

1

1 reference

14 June 2017

Kai I Cheang

2

1 reference

14 June 2017

Bhavi P Modi

3

1 reference

14 June 2017

Thushiga Kasippillai

4

1 reference

14 June 2017

Candace C Keefe

5

1 reference

14 June 2017

Maria Shulleeta

6

1 reference

14 June 2017

William S Evans

7

1 reference

14 June 2017

Lubna Pal

8

1 reference

14 June 2017

Jerome F Strauss

9

1 reference

14 June 2017

John E Nestler

10

1 reference

14 June 2017

Corrine K Welt

11

1 reference

14 June 2017

publication date

28 October 2016

1 reference

14 June 2017

1 reference

Insulin resistance in nonobese patients with polycystic ovarian disease

14 June 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effects of short-term and long-term metformin treatment on menstrual cyclicity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Responsiveness to metformin in girls with androgen excess: collective influence of genetic polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Pharmacogenetic variation and metformin response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0079

release_fbe2lgx7wjdpvhcrbwvanaknti

21 January 2018

Identifiers

DOI

10.2217/PGS-2016-0079

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fbe2lgx7wjdpvhcrbwvanaknti

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference